Skip to main content
Log in

Combined pituitary function-test with four hypothalamic releasing hormones

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Anterior pituitary function was investigated in ten healthy subjects by administering a combination of 200 µg thyrotropin releasing hormone (TRH), 100 µg gonadotropin releasing hormone (GnRH), 100 µg growth hormone releasing factor (GRF1–44), and 100 µg human corticotropin releasing factor (CRF). The same test protocol was performed in all subjects after pretreatment with 0.25 mg terguride. Five subjects were tested only with TRH and GnRH, five only with CRF, and six only with GRF. There was a prompt increase in all hormones after the administration of the four releasing hormones (RH). Pretreatment with terguride lowered the prolactin (PRL) increase (p<0.01) as well as the thyrotropin (TSH) peak (p<0.05) compared with the test without dopamine agonist pretreatment. The PRL levels after combined RH administration were significantly higher than after TRH and GnRH alone. Although four of the five subjects had higher TSH levels after combined RH administration than after TRH and GnRH alone, the difference was not significant. Other hormones were not significantly influenced by the combined RH administration or dopamine agonist pretreatment. Despite the fact that the interaction of the different releasing hormones and dopamine agonists influences the pituitary hormone response, combined RH administration seems to be a useful test for evaluating pituitary function also in patients receiving dopamine agonist therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACTH:

Adrenocorticotropic hormone

CRF:

Human corticotropin releasing factor

DA:

Dopamine

FSH:

Follicle-stimulating hormone

GH:

Human growth hormone

GnRH:

Gonadotropin releasing hormone

GRF; GRF1–44 :

Growth hormone releasing factor

LH:

Luteinizing hormone

PRL:

Prolactin

RH:

Releasing hormone (s)

RIA:

Radioimmunoassay

SE:

Standard error

TRH:

Thyrotropin releasing hormone

TSH:

Thyrotropin

References

  1. Bernutz C, König A, Horn K, Pickardt CR (1986) Advantages for sensitive assays for thyreotropin in diagnosis of thyroid disorders. J Clin Chem Clin Biochem 24:

  2. Dorow R, Breitkopf M, Gräf KJ, Horowski R (1983) Neuroendocrine effects of lisuride and its 9, 10-dihydrogenated analog in healthy volunteers. In: Calne DB, Horowski R, McDonald RJ, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 161–174

    Google Scholar 

  3. Greenwood FC, Landon J, Stamp TCB (1966) The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin. I. In control subjects. J Clin Invest 45:429–436

    Google Scholar 

  4. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218:585–589

    Google Scholar 

  5. Harsoulis P, Marshall JC, Kuku SF, Burke CW, London DR, Fraser TR (1973) Combined test for assessment of anterior pituitary function. Br Med J 4:326–329

    Google Scholar 

  6. Holl R, Fink P, Hetzel WD (1985) Combined pituitary stimulation test with releasing hormones. Acta Endocrinol [Suppl] 108:18 (Abstract 20)

    Google Scholar 

  7. Holl R, Fehm HL, Hetzel WD, Heinze E, Voigt KH (1985) Globaler Hypophysenstimulationstest mit Releasing-Hormonen. DMW 110:953–955

    Google Scholar 

  8. Looij BJ Jr, Mudde AH, Frölich M, Grossman A, Besser GM, Nieuwenhuijzen Kruseman AC (1985) Stimulation of the human anterior pituitary by hpGRF (1–29)-NH2 and interaction with hypothalamic hormones. Eur J Clin Invest 15:A6

  9. Losa M, Schopohl J, Müller OA, von Werder K (1985) Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects. Acta Endocrinol 109:467–473

    Google Scholar 

  10. Müller OA, Fink R, Baur X, Ehbauer M, Madler M, Scriba PC (1978) ACTH im Plasma: Extraktion und Bestimmung. GIT Labormed 2:117–124

    Google Scholar 

  11. Mortimier CH, Besser GM, McNeilly AS, Tunbridge WMG, Gomez-Pan A, Hall R (1973) Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH/FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) 2:317–326

    Google Scholar 

  12. Del Pozo E, Friesen H, Burmeister P (1973) Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). Schweiz Med Wochenschr 103:147–148

    Google Scholar 

  13. Scanlon MF, Weightman DR, Shale DJ, More B, Heath M, Snow MH, Lewis M, Hall R (1979) Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin Endocrinol (Oxf) 10:7–15

    Google Scholar 

  14. Sheldon WR jr, DeBold CR, Evans WS, De Cherney GS, Jackson RV, Island DP, Thorner MO, Orth DN (1985) Rapid sequencial intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects. J Clin Endocrinol Metab 60:623–630

    Google Scholar 

  15. Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S (1983) Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO 2:775–779

    Google Scholar 

  16. Stalla GK, Giesemann G, Müller OA, Wood WG, Scriba PC (1981) The development of a direct homologous radioimmunoassay for serum cortisol. J Clin Chem Biochem 19:427–434

    Google Scholar 

  17. Stalla GK, Hartwimmer J, von Werder K, Müller OA (1984) Ovine (o) and human (h) corticotropin releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity. Acta Endocrinol 106:289–297

    Google Scholar 

  18. Wehrenberg WB, Baird A, Ying SY, Rivier C, Ling N, Guillemin R (1984) Multiple sitmulation of the adenohypophysis by combination of hypothalamic releasing factors. Endocrinology 114:1995–2001

    Google Scholar 

  19. von Werder K (1975) Wachstumshormone und Prolaktinsekretion des Menschen. Urban und Schwarzenberg, München, Berlin, Wien

    Google Scholar 

  20. von Werder K, Felixberger F, Gottsmann M, Kerner K, Glöckner B (1978) The homologous human prolactin (hPRL) radioimmunoassay with an antibody against little hPRL. In: Radioimmunoassay and related procedures in medicine. IAEA, Vienna, pp 43–56

    Google Scholar 

  21. von Werder K, Müller OA, Hartl R, Losa M, Stalla GK (1984) Growth hormone releasing factor (hpGRF)-stimulation test in normal controls and acromegalic patients. J Endocrinol Invest 7:185–191

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Deutsche Forschungsgemeinschaft (We 439/5-1 and Mu 585/2-2).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schopohl, J., Losa, M., König, A. et al. Combined pituitary function-test with four hypothalamic releasing hormones. Klin Wochenschr 64, 314–318 (1986). https://doi.org/10.1007/BF01711949

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01711949

Key words

Navigation